Euroresearch is an Italian company that was founded in 1983. It operates in various pharmaceutical fields, with particular focus on research and development, marketing, licensing and trading. With over 30 years of experience, Euroresearch has developed high quality products and positioned itself as a leading company in the collagen market. Because of its well-established manufacturing processes, Euroresearch products typically have a high degree of purity and safety, thus ensuring optimum quality. The company’s mission began with research and development of highly effective, innovative solutions for the treatment of chronic injuries. Based on this experience, Euroresearch developed the idea of investing in new technological solutions in the following areas: aesthetic medicine, traumatology and dentistry.
Medical Device CE, Class III. Injectable Nithya is available in packages of three 70 mg vials.
For treating chrono – and photoaging of face, neck and hands. For the regeneration of dermal and subdermal connective tissue via stimulation of fibroblasts and neocollagenesis. For remodelling genetic deformations, such as dermal hypotrophy and hypotonia, and compromised skin elasticity
Instructions for use
Suspend the micronized collagen contained in one vial in 5 ml of physiological solution. Each vial of micronized collagen powder must be put into suspension immediately before use.
Divide the 5 ml of collagen suspension into five 1 ml syringes. This will facilitate distribution of the product: face (2-3 cc), neck (0.5-1 cc), décolleté (0.5-1 cc), and hands (0.5 cc). The product should be injected around the mouth and eyes in micro-punctures (0.1-0.2 cc and/or 0.05 cc each). Administer using fine needles (30-32 G) at the deep dermal level or at the dermal-subdermal interface (4 mm needle).
Medical Device CE, Class III. Injectable Nithya is available in a package containing one 200 mg vial.
For treating cellulite, scars, stretch marks, sagging following aesthetic surgery such as liposuction. Nithya Body is also indicated for treating body blemishes arising from chronoaging
Instructions for use
Suspend the micronized collagen in the vial in 10 ml of physiological solution.
Injection poins Each vial of micronized collagen powder must be put into suspension immediately before use. Divide the 10 ml of collagen suspension into four 2.5 cc syringes. This will facilitate distribution of the product: Inner arm and thigh, inject 0.1 cc of suspension at each puncture point at the deep dermal level using a 4 mm 30 G needle; Stretch marks, tunnelling technique, injecting 1 cc of suspension using a 13 mm, 30 G needle; Abdomen, micro injections of 0.2 cc every 2 cm using a 4 mm 30 G needle.
TYPE 1 COLLAGEN
The mechanism of action of type I collagen is currently the subject of renewed interest thanks to the discovery of new molecular mechanisms involved in homeostasis of the ECM. The most recent findings regarding the ECM highlight the importance of molecular analysis in understanding the mechanisms ensuring homeostasis and the alterations occurring in fibrotic processes. Nithya is composed of heterologous type I collagen micro-particles. A proprietary extraction technology produces a collagen with biomimetic properties that simulate polymerized collagen breakdown and thus stimulate fibroblast clustering and the deposition of procollagen and, as a consequence, type IV endogenous collagen.